GANIRELIX ACETATE

GANIRELIX ACETATE was reported 763 times

GANIRELIX ACETATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 OVARIAN HYPERSTIMULATION SYNDROME 256 0.1097
1 DIMINISHED OVARIAN RESERVE 1 0.0526
2 HUMAN CHORIONIC GONADOTROPIN NEGATIVE 1 0.0476
3 PREMATURE OVULATION 3 0.0385
4 OVARIAN CYST TORSION 2 0.0339
5 TUBO-OVARIAN ABSCESS 8 0.0328
6 FALLOPIAN TUBE ABSCESS 1 0.0213
7 KIDNEY ANGIOMYOLIPOMA 1 0.0200
8 TRISOMY 13 2 0.0196
9 HYPOOSMOLAR STATE 2 0.0163
10 ECTOPIC PREGNANCY TERMINATION 1 0.0159
11 ABDOMINAL WALL DISORDER 4 0.0137
12 ADNEXAL TORSION 4 0.0126
13 ADNEXA UTERI CYST 2 0.0123
14 BLOOD VISCOSITY ABNORMAL 1 0.0105
15 ABORTION SPONTANEOUS INCOMPLETE 1 0.0103
16 ANOVULATORY CYCLE 2 0.0097
17 OVARIAN RUPTURE 1 0.0085
18 PELVIC FLUID COLLECTION 6 0.0085
19 NEONATAL PNEUMONIA 2 0.0085
20 OVARIAN HAEMORRHAGE 2 0.0084
21 SALPINGO-OOPHORITIS 1 0.0082
22 OVARIAN ENLARGEMENT 3 0.0078
23 APPLICATION SITE NODULE 1 0.0073
24 OVARIAN ABSCESS 1 0.0064
25 SALPINGITIS 2 0.0063
26 HAEMOCONCENTRATION 1 0.0058
27 PROLACTIN-PRODUCING PITUITARY TUMOUR 1 0.0051
28 PERITONEAL HAEMORRHAGE 7 0.0050
29 ABORTION 14 0.0048
30 BLOOD LUTEINISING HORMONE INCREASED 1 0.0041
31 POOR QUALITY DEVICE USED 40 0.0040
32 HAEMORRHAGIC OVARIAN CYST 2 0.0035
33 BLADDER TAMPONADE 1 0.0033
34 WAIST CIRCUMFERENCE INCREASED 3 0.0029
35 MATERNAL EXPOSURE BEFORE PREGNANCY 19 0.0028
36 ADRENAL GLAND CANCER 1 0.0026
37 ABORTION MISSED 3 0.0024
38 OVARIAN DISORDER 2 0.0021
39 MORPHOEA 1 0.0021
40 ABORTION THREATENED 1 0.0020
41 THROMBOPHLEBITIS 7 0.0020
42 ASCITES 58 0.0020
43 OVARIAN FAILURE 1 0.0019
44 SUSPECTED PRODUCT TAMPERING 1 0.0018
45 NEEDLE ISSUE 48 0.0016
46 ADNEXA UTERI PAIN 2 0.0016
47 CHRONIC FATIGUE SYNDROME 2 0.0014
48 INTRA-ABDOMINAL HAEMORRHAGE 3 0.0013
49 HAEMOPERITONEUM 1 0.0012
50 HYDROTHORAX 1 0.0012
51 FOETAL DEATH 6 0.0012
52 ABSCESS DRAINAGE 1 0.0012
53 IMPLANT SITE PRURITUS 1 0.0011
54 UTERINE DILATION AND CURETTAGE 1 0.0011
55 PRODUCT OUTER PACKAGING ISSUE 1 0.0011
56 ADVERSE FOOD REACTION 1 0.0011
57 PELVIC DISCOMFORT 1 0.0011
58 RECALLED PRODUCT ADMINISTERED 10 0.0010
59 ECTOPIC PREGNANCY 3 0.0010
60 ORTHOPNOEA 3 0.0009
61 CLEFT LIP AND PALATE 1 0.0009
62 CYTOGENETIC ABNORMALITY 1 0.0009
63 SUBCLAVIAN VEIN THROMBOSIS 1 0.0009
64 HAEMATOCRIT INCREASED 2 0.0009
65 ABDOMINAL TENDERNESS 4 0.0008
66 BREECH PRESENTATION 1 0.0008
67 LACTOSE INTOLERANCE 2 0.0008
68 OVARIAN CYST RUPTURED 1 0.0008
69 SELF-MEDICATION 3 0.0007
70 INJECTION SITE HYPOAESTHESIA 1 0.0007
71 ACUTE ABDOMEN 1 0.0007
72 PELVIC PAIN 12 0.0007
73 POLYCYSTIC OVARIES 1 0.0006
74 INFERTILITY FEMALE 1 0.0006
75 BRONCHIAL DISORDER 1 0.0006
76 OVARIAN CANCER RECURRENT 1 0.0006
77 SLEEP TALKING 1 0.0006
78 LACK OF INJECTION SITE ROTATION 1 0.0006
79 HYPOPROTEINAEMIA 1 0.0005
80 HYPERCOAGULATION 1 0.0005
81 REBOUND ATOPIC DERMATITIS 1 0.0005
82 MUCOSAL DRYNESS 1 0.0005
83 POLYCYTHAEMIA 1 0.0005
84 CAPILLARY LEAK SYNDROME 1 0.0005
85 LIVEDO RETICULARIS 1 0.0005
86 ORAL PRURITUS 1 0.0004
87 PULMONARY INFARCTION 1 0.0004
88 RETROPERITONEAL HAEMORRHAGE 1 0.0004
89 SYRINGE ISSUE 7 0.0004
90 CARDIOVASCULAR DISORDER 10 0.0004
91 PRODUCT USE COMPLAINT 6 0.0004
92 POOR QUALITY PRODUCT ADMINISTERED 4 0.0004
93 BREAST SWELLING 1 0.0004
94 CLUMSINESS 1 0.0004
95 PLEURAL EFFUSION 22 0.0004
96 INTERMENSTRUAL BLEEDING 2 0.0004
97 PULMONARY PAIN 1 0.0003
98 EMERGENCY CARE 1 0.0003
99 OLIGURIA 2 0.0003
100 GASTRITIS 8 0.0003
101 ABORTION SPONTANEOUS 12 0.0003
102 EAR PRURITUS 1 0.0003
103 HEPATOCELLULAR INJURY 4 0.0003
104 ABDOMINAL PAIN LOWER 7 0.0003
105 DEVICE KINK 1 0.0003
106 CARDIAC DYSFUNCTION 1 0.0003
107 NEURODERMATITIS 1 0.0003
108 AUTOIMMUNE THYROIDITIS 1 0.0003
109 PRODUCT STORAGE ISSUE 1 0.0003
110 ABDOMINAL DISTENSION 27 0.0003
111 HYPOALBUMINAEMIA 2 0.0003
112 LOW BIRTH WEIGHT BABY 2 0.0003
113 INJECTION SITE REACTION 17 0.0002
114 MATERNAL EXPOSURE DURING PREGNANCY 22 0.0002
115 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 8 0.0002
116 HEPATIC CYTOLYSIS 3 0.0002
117 POOR PERIPHERAL CIRCULATION 1 0.0002
118 HYPERKALAEMIA 8 0.0002
119 VULVOVAGINAL DISCOMFORT 1 0.0002
120 ILEUS PARALYTIC 1 0.0002
121 NO ADVERSE EVENT 40 0.0002
122 INJECTION SITE PAPULE 1 0.0002
123 IMMUNE THROMBOCYTOPENIA 1 0.0002
124 PRODUCT QUALITY ISSUE 28 0.0002
125 FLUID OVERLOAD 3 0.0002
126 HYPOTONIA 2 0.0002
127 OVARIAN CYST 2 0.0002
128 INJECTION SITE RASH 6 0.0002
129 INJECTION SITE DISCOMFORT 2 0.0002
130 INJECTION SITE MASS 7 0.0002
131 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
132 DEVICE DIFFICULT TO USE 12 0.0002
133 PRODUCT LEAKAGE 1 0.0002
134 PREMATURE LABOUR 1 0.0002
135 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
136 NEUROLOGICAL SYMPTOM 1 0.0002
137 MYOCARDITIS 2 0.0002
138 POST PROCEDURAL HAEMORRHAGE 2 0.0002
139 TYPE 1 DIABETES MELLITUS 1 0.0002
140 HIATUS HERNIA 2 0.0002
141 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1 0.0002
142 INJECTION SITE BRUISING 12 0.0002
143 PRODUCT STORAGE ERROR 12 0.0001
144 DYSPNOEA EXERTIONAL 5 0.0001
145 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
146 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 6 0.0001
147 BRAIN FOG 2 0.0001
148 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
149 BLOOD DISORDER 1 0.0001
150 ABDOMINAL PAIN 29 0.0001
151 HYPONATRAEMIA 7 0.0001
152 INJECTION SITE URTICARIA 3 0.0001
153 ABNORMAL FAECES 1 0.0001
154 MENSTRUAL DISORDER 1 0.0001
155 CIRCULATORY COLLAPSE 2 0.0001
156 INJECTION SITE PAIN 36 0.0001
157 PRODUCT CONTAINER ISSUE 1 0.0001
158 DEVICE DEFECTIVE 2 0.0001
159 INCORRECT DOSE ADMINISTERED BY DEVICE 3 0.0001
160 DEVICE USE ISSUE 2 0.0001
161 OPTIC NEURITIS 1 0.0001
162 LEUKAEMIA 1 0.0001
163 INJECTION SITE PRURITUS 7 0.0001
164 PHARYNGEAL SWELLING 1 0.0001
165 PREMATURE BABY 3 0.0001
166 EAR DISCOMFORT 1 0.0001
167 EXPOSURE DURING PREGNANCY 6 0.0001
168 UNDERDOSE 7 0.0001
169 MOOD SWINGS 3 0.0001
170 METABOLIC ACIDOSIS 3 0.0001
171 PRODUCT PRESCRIBING ISSUE 2 0.0001
172 GASTROINTESTINAL PAIN 1 0.0001
173 INJECTION SITE NODULE 1 0.0001
174 INJECTION SITE ERYTHEMA 11 0.0001
175 APPLICATION SITE PRURITUS 2 0.0001
176 INJECTION SITE HAEMORRHAGE 7 0.0001
177 FOETAL EXPOSURE DURING PREGNANCY 7 0.0001
178 ATAXIA 1 0.0001
179 DISCOMFORT 5 0.0001
180 INJECTION SITE DISCOLOURATION 1 0.0001
181 HOT FLUSH 6 0.0001
182 DERMATITIS ALLERGIC 1 0.0001
183 INJECTION SITE IRRITATION 1 0.0001
184 INJECTION SITE SWELLING 6 0.0001
185 INJECTION SITE INDURATION 1 0.0001
186 INCORRECT PRODUCT STORAGE 1 0.0001
187 DERMATITIS ATOPIC 4 0.0001
188 ADVERSE REACTION 1 0.0001
189 ABNORMAL DREAMS 2 0.0001
190 APHONIA 1 0.0001
191 ABDOMINAL DISCOMFORT 12 0.0001
192 VAGINAL HAEMORRHAGE 3 0.0001
193 PSYCHOTIC DISORDER 2 0.0001
194 HYPOAESTHESIA ORAL 1 0.0001
195 DEVICE ADHESION ISSUE 1 0.0001
196 EMOTIONAL DISORDER 2 0.0001
197 MUSCULOSKELETAL CHEST PAIN 1 0.0001
198 MENINGIOMA 1 0.0001
199 RASH ERYTHEMATOUS 3 0.0001
200 ABSCESS 1 0.0001
201 PRODUCT USE IN UNAPPROVED INDICATION 15 0.0001
202 DYSPNOEA 34 0.0001
203 PERICARDITIS 1 0.0001
204 HEMIPARESIS 1 0.0001
205 HEADACHE 37 0.0001
206 NAUSEA 46 0.0001
207 FLATULENCE 3 0.0001
208 FEELING JITTERY 1 0.0001
209 SLEEP APNOEA SYNDROME 1 0.0001
210 EAR PAIN 1 0.0001
211 SURGERY 3 0.0001
212 PRODUCT ADMINISTRATION ERROR 1 0.0000
213 INJURY ASSOCIATED WITH DEVICE 1 0.0000
214 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
215 LUNG NEOPLASM MALIGNANT 2 0.0000
216 PERITONITIS 1 0.0000
217 VOMITING 22 0.0000
218 PRODUCT DISPENSING ERROR 1 0.0000
219 ADVERSE EVENT 4 0.0000
220 SWELLING 4 0.0000
221 MIGRAINE 4 0.0000
222 URTICARIA 7 0.0000
223 VISUAL IMPAIRMENT 5 0.0000
224 INCORRECT DOSE ADMINISTERED 9 0.0000
225 HAEMATOMA 1 0.0000
226 DEAFNESS 1 0.0000
227 ECZEMA 2 0.0000
228 MUSCULOSKELETAL PAIN 2 0.0000
229 APPLICATION SITE ERYTHEMA 1 0.0000
230 FATIGUE 29 0.0000
231 MOOD ALTERED 1 0.0000
232 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
233 INTENTIONAL DOSE OMISSION 1 0.0000
234 PALPITATIONS 4 0.0000
235 ILL-DEFINED DISORDER 2 0.0000
236 SUICIDAL IDEATION 3 0.0000
237 EPILEPSY 1 0.0000
238 BREAST CANCER 3 0.0000
239 SWOLLEN TONGUE 1 0.0000
240 PRODUCT USE ISSUE 6 0.0000
241 NIGHT SWEATS 1 0.0000
242 RHINORRHOEA 2 0.0000
243 VISUAL ACUITY REDUCED 1 0.0000
244 BLOOD PRESSURE DECREASED 2 0.0000
245 LIP SWELLING 1 0.0000
246 FUNGAL INFECTION 1 0.0000
247 SYNCOPE 3 0.0000
248 NEOPLASM MALIGNANT 2 0.0000
249 RASH 13 0.0000
250 SOMNOLENCE 6 0.0000
251 FLUSHING 3 0.0000
252 URINARY TRACT INFECTION 5 0.0000
253 HAEMATURIA 1 0.0000
254 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
255 PRURITUS 11 0.0000
256 RASH MACULAR 1 0.0000
257 DEVICE MALFUNCTION 2 0.0000
258 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
259 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
260 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
261 CRYING 1 0.0000
262 PANIC ATTACK 1 0.0000
263 ACCIDENTAL OVERDOSE 1 0.0000
264 MUSCLE SPASMS 5 0.0000
265 HEPATIC FUNCTION ABNORMAL 1 0.0000
266 WEIGHT INCREASED 6 0.0000
267 DYSARTHRIA 1 0.0000
268 UNEVALUABLE EVENT 2 0.0000
269 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
270 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
271 BLINDNESS 1 0.0000
272 ABDOMINAL PAIN UPPER 5 0.0000
273 DRUG INEFFECTIVE 32 0.0000
274 TREATMENT FAILURE 2 0.0000
275 PRODUCT DOSE OMISSION ISSUE 7 0.0000
276 DEVICE LEAKAGE 1 0.0000
277 CONSTIPATION 5 0.0000
278 PAIN 14 0.0000
279 ANGIOEDEMA 1 0.0000
280 DRY SKIN 3 0.0000
281 THERAPY NON-RESPONDER 1 0.0000
282 SKIN IRRITATION 1 0.0000
283 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
284 COGNITIVE DISORDER 1 0.0000
285 ANXIETY 6 0.0000
286 MULTIPLE SCLEROSIS 1 0.0000
287 DRY EYE 1 0.0000
288 ACUTE KIDNEY INJURY 3 0.0000
289 THERAPY CESSATION 1 0.0000
290 HAEMORRHAGE 2 0.0000
291 OVERDOSE 4 0.0000
292 RASH PRURITIC 1 0.0000
293 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
294 OEDEMA 1 0.0000
295 MEDICATION ERROR 1 0.0000
296 NECK PAIN 1 0.0000
297 BLISTER 1 0.0000
298 MYALGIA 3 0.0000
299 LETHARGY 1 0.0000
300 PRODUCT SUBSTITUTION ISSUE 1 0.0000
301 COVID-19 3 0.0000
302 IRRITABILITY 1 0.0000
303 FEELING HOT 1 0.0000
304 CHEST PAIN 3 0.0000
305 DIZZINESS 8 0.0000
306 DEVICE EXPULSION 1 0.0000
307 AMNESIA 1 0.0000
308 SWELLING FACE 1 0.0000
309 ERYTHEMA 3 0.0000
310 VISION BLURRED 2 0.0000
311 BURNING SENSATION 1 0.0000
312 SLEEP DISORDER 1 0.0000
313 SKIN BURNING SENSATION 1 0.0000
314 PERIPHERAL SWELLING 2 0.0000
315 ARTHRITIS 1 0.0000
316 FEELING ABNORMAL 3 0.0000
317 THROMBOSIS 1 0.0000
318 INTENTIONAL PRODUCT MISUSE 1 0.0000
319 DEVICE ISSUE 1 0.0000
320 HYPERSENSITIVITY 2 0.0000
321 CARDIAC DISORDER 1 0.0000
322 PULMONARY EMBOLISM 1 0.0000
323 ALOPECIA 2 0.0000
324 DYSPEPSIA 1 0.0000
325 HEART RATE INCREASED 1 0.0000
326 HYPOTENSION 2 0.0000
327 CHEST DISCOMFORT 1 0.0000
328 SINUSITIS 1 0.0000
329 HAEMOGLOBIN DECREASED 1 0.0000
330 DIARRHOEA 6 0.0000
331 INFLUENZA 1 0.0000
332 SEPSIS 1 0.0000
333 ASTHMA 1 0.0000
334 RHEUMATOID ARTHRITIS 1 0.0000
335 PYREXIA 3 0.0000
336 DECREASED APPETITE 2 0.0000
337 JOINT SWELLING 1 0.0000
338 LOSS OF CONSCIOUSNESS 1 0.0000
339 HYPERHIDROSIS 1 0.0000
340 INSOMNIA 2 0.0000
341 COUGH 2 0.0000
342 INFECTION 1 0.0000
343 MALAISE 3 0.0000
344 HYPOAESTHESIA 1 0.0000
345 DRUG INTERACTION 1 0.0000
346 CONFUSIONAL STATE 1 0.0000
347 PNEUMONIA 2 0.0000
348 TREMOR 1 0.0000
349 OFF LABEL USE 5 0.0000
350 ANAEMIA 1 0.0000
351 DEPRESSION 1 0.0000
352 WEIGHT DECREASED 1 0.0000
353 CONDITION AGGRAVATED 1 0.0000
354 FALL 1 0.0000
355 ASTHENIA 1 0.0000
356 ARTHRALGIA 1 0.0000